ArticleJournal of evidence-based medicine2021

New way, new recommendation: Individualized treatment of novel antidiabetic drugs for people living with type 2 diabetes based on the cardiorenal risks.

Xiang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.